Nancy E. Dempze’s Merck MRK Stock Holding History

Nancy E. Dempze’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$656K	Sell	5,455 -750	-12%	-$86.6K	0.36%	54
2025 Q4	$653K	Buy	6,205 +525	+9%	+$49.3K	0.34%	55
2025 Q3	$477K	Sell	5,680 -1,535	-21%	-$126K	0.26%	62
2025 Q2	$571K	Sell	7,215 -1,490	-17%	-$118K	0.33%	58
2025 Q1	$781K	Sell	8,705 -1,650	-16%	-$154K	0.47%	47
2024 Q4	$1.03M	Hold	10,355	–	–	0.59%	48
2024 Q3	$1.18M	Buy	10,355 +5,950	+135%	+$707K	0.66%	46
2024 Q2	$545K	Buy	4,405 +1,000	+29%	+$129K	0.37%	48
2024 Q1	$449K	Sell	3,405 -215	-6%	-$26.5K	0.34%	46
2023 Q4	$395K	Sell	3,620 -50	-1%	-$5.19K	0.33%	47
2023 Q3	$378K	Sell	3,670 -95	-3%	-$10.2K	0.34%	49
2023 Q2	$434K	Hold	3,765	–	–	0.37%	47
2023 Q1	$401K	Hold	3,765	–	–	0.36%	50
2022 Q4	$418K	Hold	3,765	–	–	0.41%	49
2022 Q3	$325K	Hold	3,765	–	–	0.35%	53
2022 Q2	$343K	Hold	3,765	–	–	0.34%	53
2022 Q1	$309K	Sell	3,765 -47	-1%	-$3.71K	0.23%	66
2021 Q4	$291K	Sell	3,812 -58	-1%	-$4.62K	0.2%	68
2021 Q3	$291K	Sell	3,870 -150	-4%	-$11.4K	0.23%	66
2021 Q2	$313K	Sell	4,020 -135	-3%	-$10K	0.26%	57
2021 Q1	$306K	Sell	4,155 -3,564	-46%	-$263K	0.27%	57
2020 Q4	$603K	Hold	7,719	–	–	0.55%	39
2020 Q3	$611K	Sell	7,719 -471	-6%	-$36.9K	0.62%	40
2020 Q2	$604K	Sell	8,190 -26	-0.3%	-$1.96K	0.67%	36
2020 Q1	$603K	Sell	8,216 -129	-2%	-$10.1K	0.81%	34
2019 Q4	$724K	Sell	8,345 -131	-2%	-$10.8K	0.8%	35
2019 Q3	$680K	Sell	8,476 -210	-2%	-$16.8K	0.82%	35
2019 Q2	$696K	Sell	8,686 -105	-1%	-$8.04K	0.8%	36
2019 Q1	$698K	Sell	8,791 -489	-5%	-$36.6K	0.82%	34
2018 Q4	$677K	Sell	9,280 -439	-5%	-$31K	0.94%	31
2018 Q3	$658K	Sell	9,719 -11	-0.1%	-$701	0.74%	35
2018 Q2	$564K	Sell	9,730 -5,139	-35%	-$290K	0.69%	36
2018 Q1	$773K	Sell	14,869 -315	-2%	-$17K	0.95%	30
2017 Q4	$815K	Buy	15,184 +211	+1%	+$11.7K	0.98%	30
2017 Q3	$914K	Sell	14,973 -26	-0.2%	-$1.58K	1.29%	29
2017 Q2	$918K	Sell	14,999 -66	-0.4%	-$4.02K	1.32%	29
2017 Q1	$913K	Buy	15,065 +2,428	+19%	+$147K	1.4%	28
2016 Q4	$710K	Hold	12,637	–	–	1.24%	31
2016 Q3	$752K	Sell	12,637 -26	-0.2%	-$1.52K	1.32%	27
2016 Q2	$696K	Hold	12,663	–	–	1.24%	29
2016 Q1	$639K	Sell	12,663 -734	-5%	-$35.9K	1.12%	31
2015 Q4	$675K	Buy	+13,397	New	+$675K	1.3%	26

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Nancy E. Dempze's MRK Position: Q1 2026 in Review

Nancy E. Dempze reduced its Merck (MRK) stake by 12% in Q1 2026, selling an estimated $86.6K and leaving 5,455 shares worth $656K. The position accounts for 0.36% of the portfolio, ranked #54.

Nancy E. Dempze first reported a position in MRK in Q4 2015 and has held it in 42 quarters since. The position peaked at $1.18M in Q3 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Nancy E. Dempze held 5,455 shares of Merck worth $656K as of Q1 2026.
Nancy E. Dempze sold 750 Merck shares in Q1 2026, an estimated $86.6K.
Merck made up 0.36% of Nancy E. Dempze's portfolio in Q1 2026, its #54 holding.
Nancy E. Dempze first reported a position in Merck in Q4 2015 and has held it in 42 quarters since.
Nancy E. Dempze's Merck position peaked at $1.18M in Q3 2024.
3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Nancy E. Dempze's 13F filing for Q1 2026, filed 14 May 2026.